Does Modified Ultrafiltration Affect Thromboelastography Results?



Status:Recruiting
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:4/17/2018
Start Date:January 8, 2018
End Date:May 1, 2019
Contact:Chawki F Elzein, MD
Email:chawki.elzein@advocatehealth.com
Phone:7086833029

Use our guide to learn which trials are right for you!

The study is to evaluate the effect of modified ultrafiltration on different components of
Thromboelastography (TEG) in neonates undergoing cardiac surgery using cardiopulmonary
bypass.

The study will be performed at Advocate Children's Hospital, Oak Lawn. All neonates
undergoing cardiac operations with cardiopulmonary bypass and modified ultrafiltration will
be enrolled. Parents will be consented before surgery.

After weaning from cardiopulmonary bypass and before starting modified ultrafiltration, a TEG
sample will be taken. The components studied are Reaction time (R), Coagulation time (K),
Angle, Maximum Amplitude (MA) and whole blood clot lysis index at 30 minutes (LY30). Another
TEG sample will be taken after finishing modified ultrafiltration and before protamine is
given. The different components will be compared pre and after modified ultrafiltration. The
Primary end points are the changes of the different TEG components after modified
ultrafiltration. The secondary end points are the utilization of different blood products
(packed red cells, fresh frozen plasma and platelets transfusion) during and after surgery.

Inclusion Criteria: - neonates

- congenital heart disease

- pediatric cardiac operation with cardiopulmonary bypass

- modified ultrafiltration done at the end of cardiopulmonary bypass

Exclusion Criteria: -patients older than 1 month.

- Cardiopulmonary bypass is not used

- Modified ultrafiltration is not performed
We found this trial at
1
site
Oak Lawn, Illinois 60453
Phone: 708-684-3029
?
mi
from
Oak Lawn, IL
Click here to add this to my saved trials